论文部分内容阅读
美国俄勒冈州波特兰医疗中心的疟疾研究人员Jane Kelly和她的同事研制出了一种名为吖啶酮的衍生物(被称为T3.5)不仅能够单独使用治疗身患疟疾的小鼠,而且能在低剂量使疟疾抗性药物的功效发生逆转,恢复治疗作用。Kelly及其合作者在《自然》杂志网络版上报告了这一研究成果。将其
Jane Kelly, a malaria researcher at the Portland Medical Center in Oregon, and her colleagues developed a derivative called acridone (called T3.5) that is not only able to treat mice suffering from malaria alone , But also reverses the efficacy of malaria-resistant drugs at low doses, restoring the therapeutic effect. Kelly and his collaborators report the findings in the online edition of Nature. Will it